SMAD3 and occult macular dystrophy: The ChIP system was validated by including anti‐RNA Polymerase II as the positive control (Figure 6G,H), and we revealed that RUNX2 and SMAD3 could bind to OMD promoter as predicted (Figure 6G,H).